Let's take a deeper dive now into President Trump's plan to lower pharmaceutical drug prices,

which he announced today in the Oval Office.

Stephanie Syne joins us with more.

Stephanie.

Omna, unlike in other countries in the U.S., pharmaceutical companies set the prices of drugs

with few restraints, which means in many cases we pay a lot more compared to, say,

Canadians or Europeans. The U.S. is where these companies make most of their profits,

including those that go into research and innovation for new and better drugs. President

Trump wants the prices Americans pay to be on par with the lowest prices paid in other nations.

For more on what his executive order could mean, I'm joined by Stacey Ducet-Zena,

of Vanderbilt University Medical Center. Stacey, thank you so much for joining the NewsHour.

As you know, there is bipartisan agreement that Americans pay too much for these drugs. Former President,

Biden made this a policy priority as well. What does today's EO do? And do you think it could move

the needle? Thanks very much for having me. Today's executive order is a bit light on details,

but one of the first steps that they've articulated in the executive order is to open up price negotiations with drug manufacturers.

And presumably having those negotiations take place over the next 30 days or so with the goal of having prices in the U.S. be more similar to other countries.

They also mentioned that if those negotiations are not successful at bringing down the prices substantially,

that they will take another series of actions, which would include more formal rulemaking around things

like a Most Favored Nations proposal, which we actually saw something similar to that in the

prior Trump administration. Americans pay three times as much for prescription drugs than

citizens of pure nations. Stacey, listen to what President Trump said he wants to see now.

It's called Most Favorite Nation. We are going to pay the lowest price there is in the world.

...